ARROWHEAD PHARMACEUTICALS, INC. Depreciation
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Depreciation of $578.34 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2019-08-05
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for the quarter ending 2019-06-30 was $578.34K, a 23.00% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for the quarter ending 2019-03-31 was $750.86K, a 3.09% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-12-31 was $752.25K, a 5.05% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for the quarter ending 2018-09-30 was $803.29K.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for fiscal 2018 was $3.00M, a 0.30% increase from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for fiscal 2017 was $2.99M, a 93.44% increase from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. depreciation for fiscal 2016 was $1.55M.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2019-06-30 | $578.34K 10-Q · filed 2019-08-05 | $1.33M derived: sum of 2 quarters · filed 2019-08-05 | $2.08M 10-Q · filed 2019-08-05 | $2.88M derived: sum of 4 quarters · filed 2019-08-05 |
| 2019-03-31 | $750.86K 10-Q · filed 2019-05-08 | $1.50M 10-Q · filed 2019-05-08 | $2.31M derived: sum of 3 quarters · filed 2019-05-08 | $3.06M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-12-31 | $752.25K 10-Q · filed 2019-02-07 | $1.56M derived: sum of 2 quarters · filed 2019-02-07 | $2.31M derived: sum of 3 quarters · filed 2019-08-05 | $3.04M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-09-30 | $803.29K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $1.55M derived: sum of 2 quarters · filed 2019-08-05 | $2.28M derived: sum of 3 quarters · filed 2019-08-05 | $3.00M 10-K · filed 2018-12-11 |
| 2018-06-30 | $751.13K 10-Q · filed 2019-08-05 | $1.48M derived: sum of 2 quarters · filed 2019-08-05 | $2.20M 10-Q · filed 2019-08-05 | |
| 2018-03-31 | $728.36K 10-Q · filed 2019-05-08 | $1.44M 10-Q · filed 2019-05-08 | ||
| 2017-12-31 | $716.07K 10-Q · filed 2019-02-07 | |||
| 2017-09-30 | $2.99M 10-K · filed 2018-12-11 | |||
| 2016-09-30 | $1.55M 10-K · filed 2018-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |